Cargando…
Psychopharmacological treatment for schizophrenia: less is more
Antipsychotic polypharmacy in the treatment of schizophrenia is more common in China and other Asian countries than in Western countries. The reasons for this are unclear, but it may be related to an unsubstantiated belief among clinicians that multiple medications are more likely to achieve the des...
Autor principal: | WANG, Chuanyue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shanghai Municipal Bureau of Publishing
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4858508/ https://www.ncbi.nlm.nih.gov/pubmed/27199528 http://dx.doi.org/10.11919/j.issn.1002-0829.215086 |
Ejemplares similares
-
‘Less is more’ in the Chinese context
por: XU, Yifeng
Publicado: (2015) -
The place of long-acting injectable antipsychotics in the treatment of schizophrenia
por: Kane, John M., et al.
Publicado: (2023) -
When is antidepressant polypharmacy appropriate in the
treatment of depression?
por: SI, Tianmei, et al.
Publicado: (2014) -
Comparative effectiveness study of paliperidone palmitate 6-month with a real-world external comparator arm of paliperidone palmitate 1-month or 3-month in patients with schizophrenia
por: Turkoz, Ibrahim, et al.
Publicado: (2023) -
Evaluation of antidepressant polypharmacy and other interventions for treatment-resistant depression
por: PENG, Daihui, et al.
Publicado: (2014)